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INTRODUCTION
  Parathyroid gland malignancies 
are rare, the most common of 
which is primary parathyroid 
carcinoma. 
  There are only a few reports of 
metastatic breast cancer found in 
functioning parathyroid adenomas 
  Literature suggests a predilection  
for tumors to spread to endocrine 
organs possibly due to the 
plentiful blood supply. 
  Based on autopsy studies, 
metastatic involvement of the 
parathyroid gland among known 
cancer patients is  
0.2-11.9%. 
  We present the unique case of a  
patient presenting with primary 
hyperparathyroidism, which  
ultimately lead to a diagnosis of  




SPECT demonstrates a 1.3 x  
1.2 cm nodule posterior to the 
right thyroid lobe, consistent with 
a parathyroid adenoma.
CONCLUSION
  This case represents a rare presentation of a patient who underwent 
surgery for primary hyperparathyroidism and ultimately was diagnosed 
with metastatic breast cancer first noted in the parathyroid adenoma.
  Few case reports in the literature have described known breast cancer  
with spread to the parathyroid gland.
ABSTRACT
  A 77-year-old female was referred to endocrinology for hypercalcemia. 
  Her calcium level was elevated at 10.5 mg/dL (normal 8.5-10.1 mg/dL) with an intact 
PTH of 171.3 pg/mL (normal 14.0-72.0 pg/mL), consistent with primary hyperparathyroidism. 
  She was symptomatic with polyuria, polydipsia, constipation, weakness, and recent 25 lb. 
weight loss that she attributed to decreased appetite. 
  The patient denied taking calcium supplements, personal history of kidney stones, or 
family history of MEN syndromes. 
  Her BMI was 23 kg/m2 and her physical exam was otherwise unremarkable. 
  Renal ultrasound was negative for nephrolithiasis. 
  DEXA scan confirmed osteoporosis of the left femoral neck (T score -3.5), and left 
forearm (T score -5.4) as well as osteopenia of the lumber spine (T score -1.8). 
  A Sestamibi scan noted persistent focal activity localizing to a 1.3 x 1.2cm soft tissue 
density nodule posterior to right thyroid lobe, consistent with a parathyroid adenoma. 
  She underwent a right superior and inferior parathyroidectomy based on intraoperative 
appearance of the glands. Her post-operative calcium level 8.7 mg/dL (normal 8.5-10.1 
mg/dL) and PTH level 118 pg/mL (normal 18.5 - 88.0 pg/mL). Her PTH normalized to 
59.4 pg/mL within 4 months.
  Pathology report detailed the right inferior parathyroid gland was normocellular 
parathyroid tissue, however the right superior parathyroid gland, weighing 1030mg, 
revealed hypercellular parathyroid tissue with a 0.5cm deposit of metastatic carcinoma 
consistent with breast primary. 
  Breast exam showed no abnormalities. Mammogram was negative for breast malignancy.
  Subsequently, PET scan revealed metabolically active metastases throughout pleura, 
thorax, chest wall, bones, and right colon. 
  The patient was diagnosed with stage IV hormone receptor positive and Her-2/neu 
negative breast cancer. She is currently being treated with tamoxifen.
PET CT SCAN
IMPRESSION:
1.  Metabolically active metastases 
with findings suspicious for left 
pleural metastases with a 
moderate-sized left pleural 
effusion. Hypermetabolic nodal 
disease in the thorax (hilum and 
mediastinum) concerning for 
nodal metastases. Multifocal left 
chest wall metastases. Possible 
osseous metastasis with focal 
metabolic activity involving left scapula.
2.  Multiple areas of metabolic activity in the right colon with wall 
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